Diverse functions for DNA and RNA editing in the immune system
- PMID: 20220309
- DOI: 10.4161/rna.7.2.11344
Diverse functions for DNA and RNA editing in the immune system
Abstract
Polynucleotide DNA and RNA editing enzymes alter nucleic acid sequences and can thereby modify encoded informational content. Two major families of polynucleotide editing enzymes, the AID/APOBEC cytidine deaminases (which catalyze the deamination of cytidine to uridine) and the adenosine deaminases acting on RNA (ADARs, which catalyze the deamination of adenosine to inosine), function in a variety of host defense mechanisms. These enzymes act in innate and adaptive immune pathways, with both host and pathogen targets. DNA editing by the cytidine deaminase AID mediates immunoglobulin somatic hypermutation and class switch recombination, providing the antibody response with the flexibility and diversity to defend against an almost limitless array of varied and rapidly adapting pathogenic challenges. Other cytidine deaminases (APOBEC3) restrict retroviral infection by editing viral retrogenomes. Adenosine deaminases (ADARs) shape innate immune responses by modifying host transcripts that encode immune effectors and their regulators. Here we review current knowledge of polynucleotide DNA and RNA editors with a focus on these and other functions they serve in the immune system.
Similar articles
-
RNA editing by base deamination: more enzymes, more targets, new mysteries.Trends Biochem Sci. 2001 Jun;26(6):376-84. doi: 10.1016/s0968-0004(01)01827-8. Trends Biochem Sci. 2001. PMID: 11406411 Review.
-
Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination.Nat Rev Genet. 2022 Aug;23(8):505-518. doi: 10.1038/s41576-022-00459-8. Epub 2022 Mar 7. Nat Rev Genet. 2022. PMID: 35256818 Free PMC article. Review.
-
Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.Chromosome Res. 2018 Mar;26(1-2):45-59. doi: 10.1007/s10577-018-9572-5. Epub 2018 Feb 2. Chromosome Res. 2018. PMID: 29396793 Review.
-
RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12895-8. doi: 10.1073/pnas.2135587100. Epub 2003 Oct 14. Proc Natl Acad Sci U S A. 2003. PMID: 14559972 Free PMC article.
-
DNA deamination in immunity: AID in the context of its APOBEC relatives.Adv Immunol. 2007;94:37-73. doi: 10.1016/S0065-2776(06)94002-4. Adv Immunol. 2007. PMID: 17560271 Review.
Cited by
-
NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.J Transl Med. 2018 Dec 22;16(1):370. doi: 10.1186/s12967-018-1739-5. J Transl Med. 2018. PMID: 30577810 Free PMC article.
-
Genome-wide profiling of RNA editing sites in sheep.J Anim Sci Biotechnol. 2019 Mar 12;10:31. doi: 10.1186/s40104-019-0331-z. eCollection 2019. J Anim Sci Biotechnol. 2019. PMID: 30918658 Free PMC article.
-
Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes.Mol Cell. 2017 Oct 5;68(1):26-43. doi: 10.1016/j.molcel.2017.09.029. Mol Cell. 2017. PMID: 28985508 Free PMC article. Review.
-
The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):493-508. doi: 10.1002/wrna.1226. Epub 2014 Mar 24. Wiley Interdiscip Rev RNA. 2014. PMID: 24664896 Free PMC article. Review.
-
Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.Oncotarget. 2015 Nov 3;6(34):35726-36. doi: 10.18632/oncotarget.6132. Oncotarget. 2015. PMID: 26486088 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical